Several human ER+ breast cancer cell lines, such as MCF-7, T47D and ZR75 cells, can develop estrogen-independent growth after long-term drug exposure in vitro and thus be used as breast cancer estrogen-independent tumor models in vivo [11, 12]. This evidence concerns the gene ESR1 and breast carcinoma.